Blue Owl Capital Co-CEO Marc Lipschultz discusses earnings after joining forces with Meta on AI dats centers as it continues to reinforce its long term pipline. Lipschultz spoke with Bloomberg's Dani Burger and Matt Miller.

Blue Owl Capital Co-CEO Marc Lipschultz discusses earnings after joining forces with Meta on AI dats centers as it continues to reinforce its long term pipline. Lipschultz spoke with Bloomberg's Dani Burger and Matt Miller.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Blue Owl Capital Co-CEO Marc Lipschultz Talks Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e6db164b-b85a-4659-9774-b38700fc1ffe/transcript

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on “The Close” that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on &ldquo;The Close&rdquo; that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren Talks Fed

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9c8d484e-e451-4eda-8225-b3d10170b712/transcript

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference. 

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.&nbsp;

Mike Doustdar Talks Strong Demand for Weight Loss Pills

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b653fc15-c4aa-4547-a7b7-b3d1016f9887/transcript

Nouriel Roubini, chairman at Roubini Macro Associates, discusses his bullish stance on the role of AI in driving US GDP and productivity and explains why he is downplaying geopolitical risks to markets.

Nouriel Roubini, chairman at Roubini Macro Associates, discusses his bullish stance on the role of AI in driving US GDP and productivity and explains why he is downplaying geopolitical risks to markets.

Nouriel Roubini Talks Tech Led Boom, Geopolitics

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/35659939-9dd2-43d9-a9ce-b3d10109b01a/transcript

Blue Owl Capital Co-CEO Marc Lipschultz Talks Earnings

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips